Have a personal or library account? Click to login
The bone hormones and their potential effects on glucose and energy metabolism Cover

The bone hormones and their potential effects on glucose and energy metabolism

Open Access
|Nov 2019

References

  1. Alwahsh SM, Xu M, Seyhan HA, Ahmad S, Mihm S, Ramadori G, Schultze FC. Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver. World J Gastroenterol 20, 1807–1821, 2014.10.3748/wjg.v20.i7.1807393097924587658
  2. Bouillon R, Bex M, Van Herck E, Laureys J, Dooms L, Lesaffre E, Ravussin E. Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus. J Clin Endocrinol Metab 80, 1194–1202, 1995.771408910.1210/jcem.80.4.77140897714089
  3. de Liefde II, van der Klift M, de Laet CE, van Daele PL, Hofman A, Pols HA. Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int 16, 1713–1720, 2005.10.1007/s00198-005-1909-115940395
  4. Ducy P. The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism. Diabetologia 54, 1291–1297, 2011.10.1007/s00125-011-2155-z2150374021503740
  5. Ferron M, McKee MD, Levine RL, Ducy P, Karsenty G. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 50, 568–575, 2012.10.1016/j.bone.2011.04.01721550430318126721550430
  6. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432, 917–921, 2004.10.1038/nature0310415531878
  7. Francisco V, Pino J, Gonzalez-Gay MA, Mera A, Lago F, Gomez R, Mobasheri A, Gualillo O. Adipokines and inflammation: is it a question of weight? Br J Pharmacol 175, 1569–1579, 2018.10.1111/bph.14181591339729486050
  8. Giudici KV, Fisberg RM, Marchioni DML, Peters BSE, Martini LA. Crosstalk between bone and fat tissue: associations between vitamin D, osteocalcin, adipokines, and markers of glucose metabolism among adolescents. J Am Coll Nutr 36, 273–280, 2017.10.1080/07315724.2016.127492328443718
  9. Gomez-Chou SB, Swidnicka-Siergiejko AK, Badi N, Chavez-Tomar M, Lesinski GB, Bekaii-Saab T, Farren MR, Mace TA, Schmidt C, Liu Y, Deng D, Hwang RF, Zhou L, Moore T, Chatterjee D, Wang H, Leng X, Arlinghaus RB, Logsdon CD, Cruz-Monserrate Z. Lipocalin-2 promotes pancreatic ductal adenocarcinoma by regulating inflammation in the tumor microenvironment. Cancer Res 77, 2647–2660, 2017.10.1158/0008-5472.CAN-16-1986544123028249896
  10. Guntur AR, Rosen CJ. Bone as an endocrine organ. Endocr Pract 18, 758–762, 2012.10.4158/EP12141.RA357165422784851
  11. Guo H, Jin D, Zhang Y, Wright W, Bazuine M, Brockman D, Bernlohr D, Chen, X. Lipocalin-2 deficiency impairs thermogenesis and potentiates diet-induced insulin resistance in mice. Diabetes 59, 1376–1385, 2010.10.2337/db09-1735287469820332347
  12. Herman W. The global burden of diabetes: An overview. In: Diabetes mellitus in developing countries and under-served communities (Ed. S. Dagogo-Jack), Springer International Publishing, Switzerland, pp. 1–5, 2017.10.1007/978-3-319-41559-8_1
  13. Holt SK, Karyadi DM, Kwon EM, Stanford JL, Nelson PS, Ostrander EA. Association of Megalin genetic polymorphisms with prostate cancer risk and prognosis. Clin Cancer Res 14, 3823–3831, 2008.10.1158/1078-0432.CCR-07-4566267588318559602
  14. Hvidberg V, Jacobsen C, Strong RK, Cowland JB, Moestrup SK, Borregaard N. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett 579, 773–777, 2005.10.1016/j.febslet.2004.12.03115670845
  15. Ivers RQ, Cumming RG, Mitchell P, Peduto AJ; Blue Mountains Eye Study. Diabetes and risk of fracture. Diabetes Care 24, 1198–1203, 2001.10.2337/diacare.24.7.119811423502
  16. Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 166, 495–505, 2007.10.1093/aje/kwm10617575306
  17. Kanazawa I, Yamaguchi T, Yamauchi M, Yamamoto M, Kurioka S, Yano S, Sugimoto T. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int 22, 187–194, 2011.10.1007/s00198-010-1184-720165834
  18. Kanazawa I. Osteocalcin as a hormone regulating glucose metabolism. World J Diabetes 6, 1345–1354, 2015.10.4239/wjd.v6.i18.1345468977926722618
  19. Karsenty G, Oury F, Biology without walls: the novel endocrinology of bone. Annu Rev Physiol 74, 87–105, 2012.10.1146/annurev-physiol-020911-15323322077214
  20. Lambertz J, Berger T, Mak TW, van Helden J, Weiskirchen R. Lipocalin-2 in fructose-induced fatty liver disease. Front Physiol 8, 964, 2017.2923428810.3389/fphys.2017.00964571234629234288
  21. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G. Endocrine regulation of energy metabolism by the skeleton. Cell 130, 456–469, 2007.10.1016/j.cell.2007.05.047201374617693256
  22. Liang Y, Tan A, Liang D, Yang X, Liao M, Gao Y, Jiang Y, Yao Z, Lin X, Lu Z, Wu C, Zhang S, Hu Y, Qin X, Mo Z, Li H, Zhang H. Low osteocalcin level is a risk factor for impaired glucose metabolism in a Chinese male population. J Diabetes Investig 7, 522–528, 2016.10.1111/jdi.12439493120227181428
  23. Marzolo PM, Farfan P. New insights into the roles of megalin/LRP2 and the regulation of its functional expression. Biol Res 44, 89–105, 2011.10.4067/S0716-9760201100010001221720686
  24. Mera P, Ferron M, Mosialou I. Regulation of energy metabolism by bone-derived hormones. Cold Spring Harb Perspect Med 8, a031666, 2018.10.1101/cshperspect.a031666598315928778968
  25. Mizokami A, Wang D, Tanaka M, Gao J, Takeuchi H, Matsui T, Hirata M. An extract from pork bones containing osteocalcin improves glucose metabolism in mice by oral administration. Biosci Biotechnol Biochem 80, 2176–2183, 2016.10.1080/09168451.2016.121453027460506
  26. Miyamoto T, Asaka R, Suzuki A, Takatsu A, Kashima H, Shiozawa T. Immunohistochemical detection of a specific receptor for lipocalin2 (solute carrier family 22 member 17, SLC22A17) and its prognostic significance in endometrial carcinoma. Exp Mol Pathol 91, 563–568, 2011.10.1016/j.yexmp.2011.06.00221763306
  27. Mosialou I, Shikhel S, Liu J, Maurizi A, Luo N, He Z, Huang Y, Zong H, Friedman R, Barasch J, Lanzano P, Deng L, Leibel R, Rubin M, Nickolas T, Chung W, Zeltser L, Williams K, Pessin J, Kousteni S. MC4R-dependent suppression of appetite by bone-derived lipocalin 2. Nature 543, 385–390, 2017.10.1038/nature21697597564228273060
  28. Neumann T, Lodes S, Kastner B, Franke S, Kiehntopf M, Lehmann T, Muller UA, Wolf G, Samann A. Osteocalcin, adipokines and their associations with glucose metabolism in type 1 diabetes. Bone 82, 50–55, 2016.10.1016/j.bone.2015.04.01725888930
  29. Neve A, Corrado A, Cantatore FP. Osteocalcin: skeletal and extra-skeletal effects. J Cell Physiol 228, 1149–1153, 2013.10.1002/jcp.2427823139068
  30. Palmiter RD. Physiology: Bone-derived hormone suppresses appetite. Nature 543, 320–322, 2017.10.1038/nature2150128273066
  31. Pi M, Wu Y, Quarles LD. GPRC6A mediates responses to osteocalcin in β-cells in vitro and pancreas in vivo. J Bone Miner Res 26, 1680–1683, 2011.10.1002/jbmr.39021425331507953621425331
  32. Pi M, Kapoor K, Ye R, Nishimoto SK, Smith JC, Baudry J, Quarles LD. Evidence for osteocalcin binding and activation of GPRC6A in β-cells. Endocrinology 157, 1866–1880, 2016.10.1210/en.2015-2010487087527007074
  33. Rached MT, Kode A, Silva BC, Jung DY, Gray S, Ong H, Paik JH, DePinho RA, Kim JK, Karsenty G, Kousteni S. FoxO1 expression in osteoblasts regulates glucose homeostasis through regulation of osteocalcin in mice. J Clin Invest 120, 357–368, 2010.10.1172/JCI39901279868720038793
  34. Saleem U, Mosley TH Jr, Kullo IJ. Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol 30, 1474–1478, 2010.10.1161/ATVBAHA.110.204859293991020395593
  35. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-a meta-analysis. Osteoporos Int 18, 427–444, 2007.10.1007/s00198-006-0253-417068657
  36. Visscher V, Rassekh SR, Sandor GS, Caron HN, van Dalen EC, Kremer LC, van der Pal HJ, Rogers PC, Rieder MJ, Carleton BC, Hayden MR, Ross CJ; CPNDS consortium. Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children. Pharmacogenomics 16, 1065–1076, 2015.10.2217/pgs.15.6126230641
  37. Wang Y, Zhou Y, Graves DT. FOXO transcription factors: their clinical significance and regulation. Biomed Res Int 2014, 925350, 2014.10.1155/2014/925350401684424864265
  38. Wei J, Karsenty G. An overview of the metabolic functions of osteocalcin. Rev Endocr Metab Disord 16, 93–98, 2015.10.1007/s11154-014-9307-7449932725577163
  39. Yan QW, Yang Q, Mody N, Graham TE, Hsu CH, Xu Z, Houstis NE, Kahn BB, Rosen ED. The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance. Diabetes 56, 2533–2540, 2007.1763902110.2337/db07-000717639021
DOI: https://doi.org/10.2478/enr-2019-0027 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Language: English
Page range: 268 - 273
Published on: Nov 15, 2019
Published by: Slovak Academy of Sciences, Mathematical Institute
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2019 Daniel Addai, Jacqueline Zarkos, Anna Tolekova, published by Slovak Academy of Sciences, Mathematical Institute
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.